Entera Bio Reports Q3 2023 Financial Results, Highlights Transformational Steps and Unveils ...
JERUSALEM, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”), a leader in the development of orally delivered peptides and small therapeutic proteins, today
Source: eagletribune.com